Abstract
The turnaround time for diagnosis of maple syrup urine disease (MSUD) by classic serum amino acid analyses often requires 3–4 days. This is due to the need for branched-chain amino acids (BCAA) to accumulate in the serum of the newborn before testing. The accumulation of BCAAs in infants with MSUD during this time increases the risk of the infant becoming clinically symptomatic. We have developed a noninvasive DNA-based mismatch PCR-RFLP assay for the Y393N BCKDHA allele (E1α gene of the branched chain α-keto acid dehydrogenase complex), the primary cause of MSUD in Old Order Mennonite communities. The homozygosity and high frequency of this mutation in the Mennonite community and its prevalence in compound heterozygote non-Mennonite MSUD patients is of significance. We describe carrier testing, present the results of nine newborns diagnostically evaluated for the Y393N BCKDHA allele, and demonstrate the efficacy of this PCR-RFLP assay for determining clinical status within 24 h after birth. Analyses within the first 24h of life allow for immediate diagnosis and treatment of infants homozygous for the Y393N MSUD defect. This is a significant improvement over the time required by current serum amino acid analysis methods.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Ævarsson A, Chuang JL, Wynn RM, et al (2000) Crystal structure of human branched chain α-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure 8: 277-291.
Chace, DH, Hillman SL, Millington DS, Kahler SG, Roe CR, Naylor EW (1995) Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry. Clinical Chemistry 41: 62-68.
Chuang DT, Shih VE (1995) Disorders of branched chain amino acids and keto acid metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 1239-1277.
Committee on Genetics (1996) Newborn Screening Fact Sheets. Pediatrics 98: 473-501.
Danner DJ, Doering CB (1998) Human mutations affecting branched chain α-keto acid dehydrogenase. Frontiers in Bioscience 3: d517-524.
DiGeorge AM, Rezvani I, Garibaldi LR, et al (1982) Prospective study of maple syrup urine disease for the first four days of life. N Engl J Med 307: 1492-1495.
Fisher CW, Chuang JL, Griffin TA, et al (1989) Molecular phenotypes in cultured maple syrupurine disease cells: complete E1 alpha cDNA sequence and mRNA and subunit contents of the human branched chain alpha-keto acid dehydrogenase complex. J Biol Chem 264: 3448-3453.
Fisher CR, Chuang JL, Cox RP, et al (1991a) Maple syrup urine disease in Mennonites: evidence that the Y393N mutation in E1α impedes assembly of the E1α component of the branched chain α-keto acid dehydrogenase complex. J Clin Invest 88: 1034-1037.
Fisher CR, Fisher CW, Chuang DT, et al (1991b) Occurrence of a Tyr393 to Asn (Y393N) mutation in the E1α gene of the branched-chain α-keto acid dehydrogenase complex in maple syrup urine disease patients from a Mennonite population. Am J Hum Genet 49: 429-434.
Marshall L, DiGeorge A (1981) Maple syrup urine disease in the old Order Mennonites. Am J Hum Genet 33: 139A.
Matsuda I, Nobukuni Y, Mitsubuchi H, et al (1990) A T to A substitution in the E1α subunit gene of the branched chain α-keto acid dehydrogenase complex in two cell lines derived from Mennonite maple syrup urine disease patients. Biochem Biophys Res Commun 172: 646-651.
McCabe ERB, Huang SZ, Seltzer WK, et al (1987) DNA microextraction from dried blood spots on filter paper blotters: potential applications to newborn screening. Hum Genet 75: 213-216.
Mitsubuchi H, Matsuda I, Nobukuni Y, et al (1992) Gene analysis of Mennonite maple syrup urine disease kindred using primer-specified restriction map modification. J Inherit Metab Dis 15: 181-187.
Naylor EW (1993) Newborn screening for maple syrup urine disease (branched-chain ketoaciduria). In: Therrell BL, ed. Laboratory Methods for Neonatal Screening. Washington DC: American Public Health Association, 115-124.
Nobukuni Y, Mitsubuchi H, Hayashida Y, et al (1993) Heterogeneity of mutations in maple syrup urine disease (MSUD): screening and identification of affected E1α subunits of the branched chain α-keto acid dehydrogenase multienzyme complex. Biochimica et Biophysica Acta 1225: 64-70.
Shih VE (1984) Maple-syrup-urine disease. N Engl J Med 310: 596-597.
Phillips CL, Dyer JA, Hillman RE, et al (1997) High frequency of the Y393N mutation in the E1α subunit of the branched chain α-keto acid dehydrogenase complex in non-Mennonite maple syrup urine disease patients. Am J Hum Genet 61: 259A.
Zhang B, Edenberg HJ, Crabb DW, et al (1989) Evidence for both a regulatory mutation and a structural mutation in a family with maple syrup urine disease. J Clin Invest 83: 1425-1429.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Love-Gregory, L.D., Dyer, J.A., Grasela, J. et al. Carrier detection and rapid newborn diagnostic test for the common Y393N maple syrup urine disease allele by PCR-RFLP: Culturally permissible testing in the Mennonite community. J Inherit Metab Dis 24, 393–403 (2001). https://doi.org/10.1023/A:1010517005001
Issue Date:
DOI: https://doi.org/10.1023/A:1010517005001